PRMT5 and lymphoma: Cyclin D1T286A activates PRMT5 through the phosphorylation of the methylosome protein 50 (MEP50), leading to methylation followed by an inhibition of p53-dependent apoptosis of leukemia and lymphoma cell lines [74].